Survivorship

Cognitive function, Version 1.2014; Clinical practice guidelines in oncology

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O'Connor & 9 others Linda Overholser, Electra D. Paskett, Muhammad Raza, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole R. McMillian, Deborah A. Freedman-Cass

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Cognitive impairment is a common complaint among cancer survivors and may be a consequence of the tumors themselves or direct effects of cancer-related treatment (eg, chemotherapy, endocrine therapy, radiation). For some survivors, symptoms persist over the long term and, when more severe, can impact quality of life and function. This section of the NCCN Guidelines for Survivorship provides assessment, evaluation, and management recommendations for cognitive dysfunction in survivors. Nonpharmacologic interventions (eg, instruction in coping strategies; management of distress, pain, sleep disturbances, and fatigue; occupational therapy) are recommended, with pharmacologic interventions as a last line of therapy in survivors for whom other interventions have been insufficient.

Original languageEnglish (US)
Pages (from-to)976-986
Number of pages11
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume12
Issue number7
DOIs
StatePublished - Jul 1 2014

Fingerprint

Practice Guidelines
Cognition
Survivors
Survival Rate
Second Primary Neoplasms
Occupational Therapy
Pain Management
Fatigue
Neoplasms
Sleep
Radiotherapy
Quality of Life
Guidelines
Drug Therapy
Cognitive Dysfunction
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Denlinger, C. S., Ligibel, J. A., Are, M., Baker, K. S., Demark-Wahnefried, W., Friedman, D. L., ... Freedman-Cass, D. A. (2014). Survivorship: Cognitive function, Version 1.2014; Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 12(7), 976-986. https://doi.org/10.6004/jnccn.2014.0094

Survivorship : Cognitive function, Version 1.2014; Clinical practice guidelines in oncology. / Denlinger, Crystal S.; Ligibel, Jennifer A.; Are, Madhuri; Baker, K. Scott; Demark-Wahnefried, Wendy; Friedman, Debra L.; Goldman, Mindy; Jones, Lee; King, Allison; Ku, Grace H.; Kvale, Elizabeth; Langbaum, Terry S.; Leonardi-Warren, Kristin; McCabe, Mary S.; Melisko, Michelle; Montoya, Jose G.; Mooney, Kathi; Morgan, Mary Ann; Moslehi, Javid J.; O'Connor, Tracey; Overholser, Linda; Paskett, Electra D.; Raza, Muhammad; Syrjala, Karen L.; Urba, Susan G.; Wakabayashi, Mark T.; Zee, Phyllis; McMillian, Nicole R.; Freedman-Cass, Deborah A.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 12, No. 7, 01.07.2014, p. 976-986.

Research output: Contribution to journalArticle

Denlinger, CS, Ligibel, JA, Are, M, Baker, KS, Demark-Wahnefried, W, Friedman, DL, Goldman, M, Jones, L, King, A, Ku, GH, Kvale, E, Langbaum, TS, Leonardi-Warren, K, McCabe, MS, Melisko, M, Montoya, JG, Mooney, K, Morgan, MA, Moslehi, JJ, O'Connor, T, Overholser, L, Paskett, ED, Raza, M, Syrjala, KL, Urba, SG, Wakabayashi, MT, Zee, P, McMillian, NR & Freedman-Cass, DA 2014, 'Survivorship: Cognitive function, Version 1.2014; Clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 12, no. 7, pp. 976-986. https://doi.org/10.6004/jnccn.2014.0094
Denlinger, Crystal S. ; Ligibel, Jennifer A. ; Are, Madhuri ; Baker, K. Scott ; Demark-Wahnefried, Wendy ; Friedman, Debra L. ; Goldman, Mindy ; Jones, Lee ; King, Allison ; Ku, Grace H. ; Kvale, Elizabeth ; Langbaum, Terry S. ; Leonardi-Warren, Kristin ; McCabe, Mary S. ; Melisko, Michelle ; Montoya, Jose G. ; Mooney, Kathi ; Morgan, Mary Ann ; Moslehi, Javid J. ; O'Connor, Tracey ; Overholser, Linda ; Paskett, Electra D. ; Raza, Muhammad ; Syrjala, Karen L. ; Urba, Susan G. ; Wakabayashi, Mark T. ; Zee, Phyllis ; McMillian, Nicole R. ; Freedman-Cass, Deborah A. / Survivorship : Cognitive function, Version 1.2014; Clinical practice guidelines in oncology. In: JNCCN Journal of the National Comprehensive Cancer Network. 2014 ; Vol. 12, No. 7. pp. 976-986.
@article{652db440a2674a108af599bb4a0e2581,
title = "Survivorship: Cognitive function, Version 1.2014; Clinical practice guidelines in oncology",
abstract = "Cognitive impairment is a common complaint among cancer survivors and may be a consequence of the tumors themselves or direct effects of cancer-related treatment (eg, chemotherapy, endocrine therapy, radiation). For some survivors, symptoms persist over the long term and, when more severe, can impact quality of life and function. This section of the NCCN Guidelines for Survivorship provides assessment, evaluation, and management recommendations for cognitive dysfunction in survivors. Nonpharmacologic interventions (eg, instruction in coping strategies; management of distress, pain, sleep disturbances, and fatigue; occupational therapy) are recommended, with pharmacologic interventions as a last line of therapy in survivors for whom other interventions have been insufficient.",
author = "Denlinger, {Crystal S.} and Ligibel, {Jennifer A.} and Madhuri Are and Baker, {K. Scott} and Wendy Demark-Wahnefried and Friedman, {Debra L.} and Mindy Goldman and Lee Jones and Allison King and Ku, {Grace H.} and Elizabeth Kvale and Langbaum, {Terry S.} and Kristin Leonardi-Warren and McCabe, {Mary S.} and Michelle Melisko and Montoya, {Jose G.} and Kathi Mooney and Morgan, {Mary Ann} and Moslehi, {Javid J.} and Tracey O'Connor and Linda Overholser and Paskett, {Electra D.} and Muhammad Raza and Syrjala, {Karen L.} and Urba, {Susan G.} and Wakabayashi, {Mark T.} and Phyllis Zee and McMillian, {Nicole R.} and Freedman-Cass, {Deborah A.}",
year = "2014",
month = "7",
day = "1",
doi = "10.6004/jnccn.2014.0094",
language = "English (US)",
volume = "12",
pages = "976--986",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "7",

}

TY - JOUR

T1 - Survivorship

T2 - Cognitive function, Version 1.2014; Clinical practice guidelines in oncology

AU - Denlinger, Crystal S.

AU - Ligibel, Jennifer A.

AU - Are, Madhuri

AU - Baker, K. Scott

AU - Demark-Wahnefried, Wendy

AU - Friedman, Debra L.

AU - Goldman, Mindy

AU - Jones, Lee

AU - King, Allison

AU - Ku, Grace H.

AU - Kvale, Elizabeth

AU - Langbaum, Terry S.

AU - Leonardi-Warren, Kristin

AU - McCabe, Mary S.

AU - Melisko, Michelle

AU - Montoya, Jose G.

AU - Mooney, Kathi

AU - Morgan, Mary Ann

AU - Moslehi, Javid J.

AU - O'Connor, Tracey

AU - Overholser, Linda

AU - Paskett, Electra D.

AU - Raza, Muhammad

AU - Syrjala, Karen L.

AU - Urba, Susan G.

AU - Wakabayashi, Mark T.

AU - Zee, Phyllis

AU - McMillian, Nicole R.

AU - Freedman-Cass, Deborah A.

PY - 2014/7/1

Y1 - 2014/7/1

N2 - Cognitive impairment is a common complaint among cancer survivors and may be a consequence of the tumors themselves or direct effects of cancer-related treatment (eg, chemotherapy, endocrine therapy, radiation). For some survivors, symptoms persist over the long term and, when more severe, can impact quality of life and function. This section of the NCCN Guidelines for Survivorship provides assessment, evaluation, and management recommendations for cognitive dysfunction in survivors. Nonpharmacologic interventions (eg, instruction in coping strategies; management of distress, pain, sleep disturbances, and fatigue; occupational therapy) are recommended, with pharmacologic interventions as a last line of therapy in survivors for whom other interventions have been insufficient.

AB - Cognitive impairment is a common complaint among cancer survivors and may be a consequence of the tumors themselves or direct effects of cancer-related treatment (eg, chemotherapy, endocrine therapy, radiation). For some survivors, symptoms persist over the long term and, when more severe, can impact quality of life and function. This section of the NCCN Guidelines for Survivorship provides assessment, evaluation, and management recommendations for cognitive dysfunction in survivors. Nonpharmacologic interventions (eg, instruction in coping strategies; management of distress, pain, sleep disturbances, and fatigue; occupational therapy) are recommended, with pharmacologic interventions as a last line of therapy in survivors for whom other interventions have been insufficient.

UR - http://www.scopus.com/inward/record.url?scp=84903965184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903965184&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2014.0094

DO - 10.6004/jnccn.2014.0094

M3 - Article

VL - 12

SP - 976

EP - 986

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 7

ER -